← Back to guidelines
Cardiology98 papers

Central neurocytoma

Last edited: 4/22/2026

Overview

Central neurocytomas are rare, typically benign intraventricular tumors originating from neuronal progenitor cells, often diagnosed in adolescents and young adults. They can present atypically with intraventricular hemorrhage, complicating initial diagnosis and management 1.

Diagnosis

  • Imaging: CT and MRI are essential, showing a mass lesion often within the lateral or third ventricle 1.
  • Histopathology: Definitive diagnosis requires surgical resection and pathological examination confirming the characteristic features of central neurocytoma 1.
  • Hemorrhagic Presentation: Recognize central neurocytoma as a potential cause of intraventricular hemorrhage, particularly in younger patients 1.
  • Management

  • Surgical Resection: Complete removal of the tumor is often curative and associated with favorable outcomes 1.
  • Adjunctive Treatments: Radiotherapy, radiosurgery, or chemotherapy may be necessary in cases with aggressive behavior or incomplete resection 1.
  • Special Populations

  • Adolescents and Young Adults: Central neurocytomas predominantly affect this age group, with hemorrhagic presentations noted more frequently 1.
  • Key Recommendations

  • Suspect central neurocytoma in young patients presenting with intraventricular hemorrhage (Evidence: Moderate 1).
  • Prioritize complete surgical resection for optimal outcomes (Evidence: Strong 1).
  • Consider adjunctive therapies (radiotherapy, radiosurgery, chemotherapy) for aggressive cases or incomplete resection (Evidence: Weak 1).
  • References

    1 Smets K, Salgado R, Simons PJ, De Clercq R, De Smedt K, Cras P. Central neurocytoma presenting with intraventricular hemorrhage: case report and review of literature. Acta neurologica Belgica 2005. link

    Original source

    1. [1]
      Central neurocytoma presenting with intraventricular hemorrhage: case report and review of literature.Smets K, Salgado R, Simons PJ, De Clercq R, De Smedt K, Cras P Acta neurologica Belgica (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG